DURECT Corporation - Common Stock (DRRX)
1.9100
+0.0300 (1.60%)
NASDAQ · Last Trade: Jul 31st, 3:54 AM EDT
Specificity Inc. (OTCID: SPTY), a next-generation digital marketing firm, has regained its status as a fully reporting SEC current filer—marking a key milestone as it continues to revolutionize audience targeting across digital platforms. Known for eliminating bots and irrelevant impressions, Specificity’s proprietary ad tech delivers precision-targeted ads across display, social, and Connected TV (CTV) to the same verified, high-intent audiences —maximizing ROI and minimizing waste.
Via AB Newswire · July 29, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of DURECT Corporation (NASDAQ: DRRX) to Bausch Health Companies Inc. for $1.75 per share is fair to DURECT shareholders.
By Halper Sadeh LLC · Via Business Wire · July 29, 2025
The Ademi Firm is investigating DURECT (NYSE: DRRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Bausch Health.
By Ademi & Fruchter LLP · Via Business Wire · July 29, 2025
Durect Corp. (NASDAQ: DRRX) Making Surprising Moves in Monday Session
DURECT Corporation (NASDAQ: DRRX) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 9.88% on the day to $4.45.
Via Investor Brand Network · April 10, 2023